• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肠道药物测压法与葡萄糖耐量:人体中两种拮抗多巴胺能机制的证据。

Intestinal pharmacomanometry and glucose tolerance: evidence for two antagonistic dopaminergic mechanisms in the human.

作者信息

Lechin F, van der Dijs B

出版信息

Biol Psychiatry. 1981 Oct;16(10):969-86.

PMID:7306619
Abstract

In this article cumulative data are presented dealing with the existence of more than one dopamine receptor in mammals. In addition, evidence is presented for the existence of two antagonistic dopamine-functional expressions in the human. This fact, along with the disclosure of new dopaminergic agonistic and antagonistic drugs, should prove useful in the management of diseases in which these drugs have proven to be good therapeutic tools.

摘要

本文展示了关于哺乳动物中存在不止一种多巴胺受体的累积数据。此外,还提供了证据证明人类中存在两种拮抗性多巴胺功能表达。这一事实,连同新的多巴胺能激动剂和拮抗剂药物的披露,在这些药物已被证明是良好治疗工具的疾病管理中应会证明是有用的。

相似文献

1
Intestinal pharmacomanometry and glucose tolerance: evidence for two antagonistic dopaminergic mechanisms in the human.肠道药物测压法与葡萄糖耐量:人体中两种拮抗多巴胺能机制的证据。
Biol Psychiatry. 1981 Oct;16(10):969-86.
2
Intestinal pharmacomanometry and glucose tolerance: two kinds of dopaminergic mechanisms in the human.肠道药物测压法与葡萄糖耐量:人体中的两种多巴胺能机制。
Acta Gastroenterol Latinoam. 1981;11(2):247-59.
3
Effects of diphenylhydantoin (DPH) on distal colon motility.苯妥英(DPH)对远端结肠运动的影响。
Acta Gastroenterol Latinoam. 1979;9(3):145-52.
4
Effects of dopaminergic blocking agents on distal colon motility.多巴胺能阻滞剂对结肠远端运动的影响。
J Clin Pharmacol. 1979 Oct;19(10):617-25. doi: 10.1002/j.1552-4604.1979.tb01624.x.
5
[The role of dopamine in the gastrointestinal tract and its relation to intestinal peptides].[多巴胺在胃肠道中的作用及其与肠道肽的关系]
Med Clin (Barc). 1988 Jan 9;90(1):28-32.
6
Dopamine: pharmacologic and therapeutic aspects.多巴胺:药理学与治疗学方面
Am J Ther. 1998 Jan;5(1):37-43.
7
Dopaminergic mechanisms in the conditioned and unconditioned fear as assessed by the two-way avoidance and light switch-off tests.通过双向回避和熄灯测试评估条件性和非条件性恐惧中的多巴胺能机制。
Pharmacol Biochem Behav. 2004 Oct;79(2):359-65. doi: 10.1016/j.pbb.2004.08.006.
8
[Effect of prokinetic drugs inhibiting dopaminergic system on gallbladder motility in subjects with duodenal ulcer].[促动力药物抑制多巴胺能系统对十二指肠溃疡患者胆囊运动的影响]
Pol Merkur Lekarski. 1999 Apr;6(34):188-91.
9
Effect of long-term treatment with haloperidol and sulpiride on different types of dopaminergic receptors.
Adv Biochem Psychopharmacol. 1980;24:275-81.
10
S 16924 ((R)-2-[1-[2-(2,3-dihydro-benzo[1,4] dioxin-5-Yloxy)-ethyl]-pyrrolidin-3yl]-1-(4-fluoro-phenyl)-ethanone), a novel, potential antipsychotic with marked serotonin (5-HT)1A agonist properties: I. Receptorial and neurochemical profile in comparison with clozapine and haloperidol.S 16924((R)-2-[1-[2-(2,3-二氢-苯并[1,4]二氧杂环己烯-5-基氧基)-乙基]-吡咯烷-3-基]-1-(4-氟苯基)-乙酮),一种具有显著5-羟色胺(5-HT)1A激动剂特性的新型潜在抗精神病药物:I. 与氯氮平和氟哌啶醇相比的受体及神经化学特征
J Pharmacol Exp Ther. 1998 Sep;286(3):1341-55.

引用本文的文献

1
Amantadine reduces glucagon and enhances insulin secretion throughout the oral glucose tolerance test: central plus peripheral nervous system mechanisms.金刚烷胺通过中枢及外周神经系统机制降低整个口服葡萄糖耐量试验中的胰高血糖素并增强胰岛素分泌。
Diabetes Metab Syndr Obes. 2009 Dec 2;2:203-13. doi: 10.2147/dmsott.s7606.
2
Anorexia nervosa depends on adrenal sympathetic hyperactivity: opposite neuroautonomic profile of hyperinsulinism syndrome.神经性厌食症依赖于肾上腺交感神经活性亢进:胰岛素过多综合征的相反神经自主神经特征。
Diabetes Metab Syndr Obes. 2010 Sep 9;3:311-7. doi: 10.2147/DMSOTT.S10744.
3
Central nervous system plus autonomic nervous system disorders responsible for gastrointestinal and pancreatobiliary diseases.
导致胃肠和胰腺胆道疾病的中枢神经系统加自主神经系统疾病。
Dig Dis Sci. 2009 Mar;54(3):458-70. doi: 10.1007/s10620-008-0369-9. Epub 2008 Jul 16.
4
Lithium attenuates the activation-euphoria but not the psychosis induced by d-amphetamine in schizophrenia.
Psychopharmacology (Berl). 1985;87(1):111-5. doi: 10.1007/BF00431789.